The Aperlena Verdict
Open raceNo supplier dominates: 255 different companies have won the last 662 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- 0%
Based on 662 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryAn urgent public tender for the purchase of a combination antiretroviral medicine containing emtricitabine 200 mg and tenofovir 245 mg in tablet form. The tender covers the supply of these pharmaceutical products, packaged as tablets, in the quantities required by the contracting authority. The medicine is used in the treatment of HIV infection and the procurement is intended to ensure a continuous stock of this therapy.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Report an error in this notice
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 4 days ago
The official portal may ask for a free registration before downloading.
More from this buyer
Full buyer profile125 open tenders right now
- Consumable medical devices - 262A000195 - Acquisition of Medical Devices for Traumatology (encavilhamento), 2026 and 2027 1 day left
- 269A000063 - Aquisição de Produtos de Apoio, para o Serviço de Medicina Física e Reabilitação (MFR), para atribuição de Ajudas Técnicas a utentes no ano de 2026 2 days left
- Aquisição de solução de segurança de perímetro 3 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| GENERIS FARMACÊUTICA S.A | 17 | €146,661 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 16 | €363,988 | Aug 2026 |
| FRESENIUS KABI PHARMA PORTUGAL, LDA. | 16 | €313,366 | Sep 2026 |
| GENERIS - FARMACEUTICA, S.A. | 15 | €357,803 | Sep 2026 |
| XPHARMA, Lda. | 14 | €51,218 | Sep 2026 |
Based on 662 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 667 comparable contracts this buyer awarded in this sector over the last 4 years.
- Lower quartile
- €1,445
- Median award
- €6,983
- Upper quartile
- €28,665
This tender is estimated 2762.2% above that median
Most recent awards
- 261Y000617/13559 - IMIPENEM 500 MG + CILASTATINA 5 €102,563
- 261G001039/13559 - AC MONOCLONAL ANTI CD123-APC €810
- 261Y000618/13559 - BRIGAtinib 30 MG COMP €2,212
- 261G001021/13559 - VÁRIOS REAGENTES €810
- 261X000268 - CANABIDIOL 100MG/ML SOL ORAL FRS 100ML €17,765
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€478,500
est. value
1
day left
€399,300
est. value
1
day left
€498,755
est. value
1
day left
€723,309
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,341,044
- Buyer track record on Aperlena
- 2,797 notices tracked · 994 awarded
- €42,520,220 in awarded contracts
Never miss a tender like this
1,132 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert